Home
|
NRI
|
Business Associates
|
Knowledge Bank
|
Careers
|
Back Office
|
Contact Us
Get Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss Accounts
Quarterly Results
Key Financial Ratios
Share Price
Charts
Quarterly Results
Parenteral Drugs (India) Ltd
Industry
: Pharmaceuticals - Indian - Formulations
Chairman
: Manoharlal Gupta
Home
: Indian Private
Book Value
: -300.6045095
BSE Code
: 524689
Market Cap
: 10.11
NSE Code
: PDPL
P / E
: 0
Change Company :
Quarters:
3
4
5
6
7
8
(Rs in Cr.)
Quarterly Results
Particulars
Mar 2022
Dec 2021
Sep 2021
Jun 2021
Type
4Qtr
3Qtr
2Qtr
1Qtr
Net Sales
1.77
1.44
2.35
2.93
Other Income
52.21
0.00
0.00
0.00
Total Income
54.02
1.45
2.36
2.94
Total Expenditure
7.66
4.67
5.62
5.57
Operating Profit
46.37
-3.21
-3.26
-2.62
Interest
0.00
36.68
35.47
34.10
Gross Profit
46.36
-39.90
-38.72
-36.72
Depreciation
27.15
4.33
4.33
4.33
Tax
0.00
0.00
0.00
0.00
Deferred Tax
-4.60
-9.70
-9.44
-9.02
Reported Profit After Tax
23.81
-34.52
-33.61
-32.04
BSE Disclaimer
|
Disclaimer
|
Privacy Statement
|
Terms of Use
|
Feedback
|
Sitemap
|
Downloads
|
Client Bank Details
Useful Links
|
Risk Disclosure
|
Rules and Regulations
|
Investor Charter
|
Investor Complaints
|
Smart ODR
|
Attention Investors
|
SEBI Saa₹thi Mobile App/SEBI Investor Website
SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved
Developed & Maintained By
C-MOTS Infotech(ISO 9001:2015 certified)
Content powered by
Capital Market
Charts are powered by
TradingView